These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4350704)

  • 21. Neuromuscular transmission in myasthenia gravis studied with single fibre electromyography.
    Stålberg E; Ekstedt J; Broman A
    J Neurol Neurosurg Psychiatry; 1974 May; 37(5):540-7. PubMed ID: 4366058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory action of Ruthenium red on neuromuscular transmission.
    Rahamimoff R; Alnaes E
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3613-6. PubMed ID: 4357869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiological studies of neuromuscular transmission in hereditary 'motor end-plate disease' of the mouse.
    Duchen LW; Stefani E
    J Physiol; 1971 Jan; 212(2):535-48. PubMed ID: 4323310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The site and mode of action of propanidid on the peripheral motor unit.
    Ellis FR
    Anaesthesist; 1971 Jan; 20(1):19-22. PubMed ID: 4322995
    [No Abstract]   [Full Text] [Related]  

  • 25. The facilitatory effects of catechol and phenol at the neuromuscular junction of the cat.
    Blaber LC; Gallagher JP
    Neuropharmacology; 1971 Mar; 10(21):153-9. PubMed ID: 4328632
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of ACTH and corticosteroids in myasthenia gravis.
    Genkins G; Kornfeld P; Osserman KE; Namba T; Grob D; Brunner NG
    Ann N Y Acad Sci; 1971 Sep; 183():369-74. PubMed ID: 4330763
    [No Abstract]   [Full Text] [Related]  

  • 27. Study of long-term anticholinesterase therapy. Effects on neuromuscular transmission and on motor end-plate fine structure.
    Engel AG; Lambert EH; Santa T
    Neurology; 1973 Dec; 23(12):1273-81. PubMed ID: 4357114
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.
    Riggs JE
    Clin Neuropharmacol; 1982; 5(3):277-92. PubMed ID: 6288236
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanism of blockade of neuromuscular transmission by pentobarbital.
    Seyama I; Narahashi T
    J Pharmacol Exp Ther; 1975 Jan; 192(1):95-104. PubMed ID: 164531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of non-quantal acetylcholine leakage by 2(4-phenylpiperidine)cyclohexanol in the mouse diaphragm.
    Vyskocil F
    Neurosci Lett; 1985 Sep; 59(3):277-80. PubMed ID: 4058798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromuscular transmission in myasthenic single motor units.
    Kadrie HA; Brown WF
    J Neurol Neurosurg Psychiatry; 1978 Mar; 41(3):205-14. PubMed ID: 204747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term effects of prednisolone on neuromuscular transmission in normal rats and those with experimental autoimmune myasthenia gravis.
    Kim YI; Goldner MM; Sanders DB
    J Neurol Sci; 1979 Apr; 41(2):223-34. PubMed ID: 220391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACTH and neuromuscular transmission: electrophysiological in vitro investigation of the effects of corticotropin and an ACTH fragment on neuromuscular transmission.
    Birnberger KL; Rüdel R; Struppler A
    Ann Neurol; 1977 Mar; 1(3):270-5. PubMed ID: 196543
    [No Abstract]   [Full Text] [Related]  

  • 34. Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology.
    Tiedt TN; Albuquerque EX; Hudson CS; Rash JE
    J Pharmacol Exp Ther; 1978 May; 205(2):326-39. PubMed ID: 205647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor nerve terminal and muscle membrane stabilization by diphenylhydantoin administration.
    Su PC; Feldman DS
    Arch Neurol; 1973 Jun; 28(6):376-9. PubMed ID: 4349630
    [No Abstract]   [Full Text] [Related]  

  • 37. The neuromuscular pharmacology of germine-3-acetate and germine-3,16-diacetate.
    Standaert FG; Detwiler PB
    J Pharmacol Exp Ther; 1970 Feb; 171(2):223-41. PubMed ID: 5459059
    [No Abstract]   [Full Text] [Related]  

  • 38. [Considerations on presynaptic neuromuscular transmission and block].
    Foldes FF
    Rev Bras Anestesiol; 1971; 21(3):277-95. PubMed ID: 4333102
    [No Abstract]   [Full Text] [Related]  

  • 39. Electrophysiological observations on the action of the purified scorpion venom, tityustoxin, on nerve and skeletal muscle of the rat.
    Warnick JE; Albuquerque EX; Diniz CR
    J Pharmacol Exp Ther; 1976 Jul; 198(1):155-67. PubMed ID: 180278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of amantadine on neuromuscular transmission.
    Tsai MC; Mansour NA; Eldefrawi AT; Eldefrawi ME; Albuquerque EX
    Mol Pharmacol; 1978 Sep; 14(5):787-803. PubMed ID: 213703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.